Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

被引:150
|
作者
Petroff, MGV
Egan, JM
Wang, XL
Sollott, SJ
机构
[1] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA
[2] NIA, Diabet Sect, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA
[3] Univ Nacl La Plata, Fac Ciencias Med, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina
关键词
cardiac myocytes; glucagon-like peptide-1; cAMP; calcium;
D O I
10.1161/hh1701.095716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7+/-0.5 to 13.1 +/- 0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO. 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pH(i) in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160+/-34%) and CaT (70+/-5%), GLP-1 induced a significant decrease in contraction amplitude (-27+/-5%) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (Delta pH(i) -0.09+/-0.02 and -0.08+/-0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to beta -adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 50 条
  • [11] Glucagon-like peptide-1 agonists
    Padwal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [12] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [13] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [14] GLUCAGON-LIKE PEPTIDE-1 BINDING TO RAT HEPATIC MEMBRANES
    VILLANUEVAPENACARRILLO, ML
    DELGADO, E
    TRAPOTE, MA
    ALCANTARA, A
    CLEMENTE, F
    LUQUE, MA
    PEREA, A
    VALVERDE, I
    JOURNAL OF ENDOCRINOLOGY, 1995, 146 (01) : 183 - 189
  • [15] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [16] Glucagon-Like Peptide-1 Increases Brain fMRI Activity in Rats
    Min, David K.
    Tuor, Ursula I.
    Chelikani, Prasanth K.
    OBESITY, 2011, 19 : S171 - S171
  • [17] Glucagon, glucagon-like peptide-1 and their receptors: An introduction
    Holst, JJ
    ACTA PHYSIOLOGICA SCANDINAVICA, 1996, 157 (03): : 309 - 315
  • [18] EFFECT OF GLUCAGON ON SECRETION OF GLUCAGON-LIKE PEPTIDE-1
    SHIMA, K
    OHBOSHI, C
    SATO, M
    HIROTA, M
    HORMONE AND METABOLIC RESEARCH, 1988, 20 (02) : 123 - 124
  • [19] Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat
    Thomson, Scott C.
    Kashkouli, Ali
    Singh, Prabhleen
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (02) : F137 - F144
  • [20] Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
    Luque, MA
    González, N
    Márquez, L
    Acitores, A
    Redondo, A
    Morales, M
    Valverde, I
    Villanueva-Peñacarrillo, ML
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 465 - 473